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Islam MR, Uramoto H, Okada T, Sabirov RZ, Okada Y.
Maxi-anion channel and pannexin 1 hemichannel constitute separate
pathways for swelling-induced ATP release in murine L929 fibrosar-
coma cells. Am J Physiol Cell Physiol 303: C924–C935, 2012. First
published July 11, 2012; doi:10.1152/ajpcell.00459.2011.—The maxi-
anion channel plays a classically recognized role in controlling the
membrane potential through the chloride conductance. It also has
novel functions as a regulated pathway for the release of the anionic
signaling molecules ATP and excitatory amino acids from cells
subjected to osmotic perturbation, ischemia, or hypoxia. Because
hemichannels formed by pannexins and connexins have been reported
to mediate ATP release from a number of cell types, these hemichan-
nels may represent the molecular correlate of the maxi-anion channel.
Here, we found that L929 fibrosarcoma cells express functional
maxi-anion channels which mediate a major portion of swelling-
induced ATP release, and that ATP released via maxi-anion channels
facilitates the regulatory volume decrease after osmotic swelling.
Also, it was found that the cells express the mRNA for pannexin 1,
pannexin 2, and connexin 43. Hypotonicity-induced ATP release was
partially suppressed not only by known blockers of the maxi-anion
channel but also by several blockers of pannexins including the
pannexin 1-specific blocking peptide 10Panx1 and small interfering
(si)RNA against pannexin 1 but not pannexin 2. The inhibitory effects
of maxi-anion channel blockers and pannexin 1 antagonists were
additive. In contrast, maxi-anion channel activity was not affected by
pannexin 1 antagonists and siRNAs against pannexins 1 and 2.
Although a connexin 43-specific blocking peptide, Gap27, slightly
suppressed hypotonicity-induced ATP release, maxi-anion channel
activity was not affected by Gap27 or connexin 43-specific siRNA.
Thus, it is concluded that the maxi-anion channel is a molecular entity
distinct from pannexin 1, pannexin 2, and connexin 43, and that the
maxi-anion channel and the hemichannels constitute separate path-
ways for swelling-induced ATP release in L929 cells.
maxi-anion channel; pannexin; connexin; hemichannel; ATP release
THE MAXI-ANION CHANNEL belongs to a group of volume-regu-
lated Cl channels and is characterized by a large unitary
single-channel conductance of approximately 300–400 pS,
sensitivity to Gd3 and arachidonic acid, and a ubiquitous
expression pattern (33, 46). The channel has been observed
from the very beginning of the patch-clamp era, but its activity
was initially considered to be nonphysiological due to its
exceedingly large amplitude. Recently, the maxi-anion channel
has attracted a great deal of attention because of its permea-
bility to anionic metabolites such as glutamate and ATP (45,
46). Studies on acutely isolated macula densa plaques (4),
cultured (14) or freshly isolated (12) cardiomyocytes, and
cultured astrocytes (23–25) have demonstrated that the channel
mediates the physiologically and pathophysiologically relevant
release of ATP and glutamate. It therefore plays a vital role in
the cell-to-cell purinergic and glutamatergic signal transduc-
tion that results in cardioprotection or neurodegeneration, de-
pending on the target cell type and the nature of the activating
stimulus.
Despite a long history of research and the important func-
tions that have been attributed to the maxi-anion channel, the
channel’s molecular nature remains to be clarified. A mito-
chondrial voltage-dependent anion channel (VDAC or porin)
expressed in the plasma membrane had long been under con-
sideration as a molecular entity corresponding to the maxi-
anion channel (42). However, the channel’s activity was
insensitive to genetic manipulations that eliminated the
expression of the Vdac1, Vdac2, and Vdac3 genes both
individually and collectively (47), refuting this attractive
hypothesis. Suzuki and Mizuno (54) and Suzuki (55) iden-
tified Ttyh genes in the human genome as possible candi-
dates for the maxi-anion channel; these genes are homolo-
gous to the Tweety gene at the Drosophila flightless locus
known to be involved in normal flying (31). However, a
maxi-anion channel-like activity could not be detected in
HEK293T cells transfected with two splice-variant clones,
TTYH1-E and TTYH1-SV, of the TTYH1 gene (33).
Recently, connexins and pannexins have been proposed to
serve as pathways for ATP release in the form of hemichannels
(11, 30, 48, 59). In the present study, we therefore addressed the
questions of whether pannexins or connexins are related to the
maxi-anion channel and whether they participate in the swelling-
induced ATP release in murine fibrosarcoma L929 cells.1
MATERIALS AND METHODS
Cells. Murine L929 fibrosarcoma cells were obtained from Dr. Koh
Ono (Kyoto University, Kyoto, Japan). The cells were cultured in
RPMI 1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supple-
mented with 0.1 mg/ml streptomycin, 40 U/ml penicillin, and 10% fetal
bovine serum (FBS) (Equitech-Bio, Kerrville, TX; or Biowest, Nuaille,
France) for all experiments. Mouse mammary fibroblast C127 cells were
cultured in high glucose Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 200 mg/l penicillin (Meiji Seika, Tokyo, Japan), 100
mg/l streptomycin (Meiji Seika), and 10% FBS and used only for DNA
microarray analysis as the control. Cells were maintained at 37°C in a 5%
CO2 incubator and were usually split every 3–4 days.
Chemicals. Adenosine 5=-triphosphate disodium salt (ATP), 5-ni-
tro-2-(3-phenylpropylamino)-benzoate (NPPB), arachidonic acid (ara-
chidonate), probenecid, mefloquine, brefeldin A, apyrase (grade I),
1-octanol, Na-HEPES, EGTA, CsCl, and CsOH were purchased from
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Cell Physiology, National Institute for Physiological Sciences, Myodaiji-cho,
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Sigma-Aldrich (St. Louis, MO). Tyrphostin A23 (AG18) was pur-
chased from TOCRIS Biosciences (Bristol, UK). GdCl3 and bafilo-
mycin A1 were purchased from WAKO (Osaka, Japan). HEPES was
obtained from DOJINDO (Kumamoto, Japan). The pannexin 1 mi-
metic blocking peptide (WRQAAFVDSY) 10Panx1 and the connexin
43 (Cx43) mimetic blocking peptide (SRPTEKTIFII) Gap27 were
from AnaSpec (Fremont, CA).
Solutions. Normal Ringer solution was composed of (in mM): 135
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 Na-HEPES, 6 HEPES, and 5
glucose (pH 7.4, 290 mosmol/kgH2O). Artificial intracellular solution
contained (in mM): 140 KCl, 5 HEPES, 5 EGTA, 1 MgCl2, and 2.543
CaCl2 (pH 7.4, adjusted with KOH; 294 mosmol/kgH2O; pCa 7.0).
For measurements of ATP permeability, a 100 mM Na4ATP solution
(pH 7.4 adjusted with NaOH) was used as the bath solution. ATP-
containing solutions were kept on ice and warmed to room tempera-
ture immediately before each experiment. For inside-out patch-clamp
experiments, the pipette was filled with normal Ringer solution, and
the bath contained normal Ringer solution, the artificial intracellular
solution, or the 100 mM Na4ATP solution. In whole cell patch-clamp
experiments, the pipette solution was composed of (in mM): 135
CsCl, 5 HEPES, 10 EGTA, 1 MgCl2, and 2 CaCl2 (pH 7.4 adjusted
with CsOH; 280 mosmol/kgH2O), and the bath contained normal
Ringer solution. For outside-out patch-clamp experiments, the pipette
solution contained (mM): 120 NaCl, 5 KCl, 5 HEPES, 10 EGTA, 1
MgCl2, and 2 CaCl2 (pH 7.4 adjusted with NaOH; 275 mosmol/
kgH2O), and the bath contained normal Ringer solution. In experi-
ments with inhibitors or blockers, the stock solutions were prepared in
DMSO and were diluted to their final concentrations immediately
before the experiments. The final DMSO concentration did not exceed
0.1%, and DMSO did not have any effect when added alone. GdCl3
was stored as a 50 or 500 mM stock solution in water. The stock
solutions of the Panx1 and Cx43 mimetic blocking peptides (10
mg/ml) were prepared in water. For the ATP release assay, we used an
isotonic 50 mM NaCl Ringer solution containing (in mM): 50 NaCl,
5 KCl, 2 CaCl2, 1 MgCl2, 5 Na-HEPES, and 6 HEPES (pH 7.4; 290
mosmol/kgH2O adjusted with mannitol). In the hypotonic 50 mM
NaCl solutions, only the amount of mannitol was varied so that the
osmolality could be changed while keeping the ionic strength at a
constant level, an essential condition for reproducibility of ATP
measurements. Osmolality of all experimental solutions was measured
with a freezing-point depression osmometer (OM802; Vogel, Kev-
elaer, Germany).
Electrophysiology. For inside-out and outside-out patch-clamp ex-
periments, L929 cells were grown on glass coverslips for 1 day before
the experiments. For whole cell experiments, suspensions of spherical
cells were prepared by detaching them from the plastic substrate and
culturing them with agitation. All patch-clamp recordings were car-
ried out at room temperature (23–25°C). Patch pipettes were pulled
from borosilicate glass capillaries (outer diameter 1.4 mm, inner
diameter 1.0 mm) with a micropipette puller (model P-97; Sutter
Instruments, Novato, CA) and had a tip resistance of 2 M when
filled with the pipette solution. For whole cell recordings, the access
resistance did not exceed 5 M and was always compensated for (by
70–80%). Fast and slow capacitative transients were routinely com-
pensated for. Single-channel recordings were made using the excised,
inside-out or outside-out configuration of the patch-clamp technique.
Membrane currents were measured with an Axopatch 200A patch-
clamp amplifier coupled to a Digidata 1320 interface (Axon Instru-
ments, Union City, CA). The time course of current change was
monitored by repetitively applying (every 5 s) alternating step pulses
(500-ms duration) to 25 mV from a holding potential of 0 mV. To
observe voltage dependence of the current profile, step pulses were
applied with command voltages up to 50 mV in 10-mV increments.
Data acquisition and analysis were done with pClamp software
(version 9.0.2; Axon Instruments) and WinASCD software (kindly
provided by Dr. G. Droogmans, KU Leuven, Belgium). The mem-
brane potential was controlled by shifting the pipette potential (Vp)
and reported as Vp for whole cell and outside-out recordings and Vp
for inside-out recordings. Current signals were filtered at 2 kHz and
digitized at 5 kHz. The liquid junction potentials were calculated with
pCLAMP software and corrected when necessary. When the bath Cl
concentration was changed, a salt bridge containing 3 M KCl in 2%
agarose was used to minimize the bath electrode potential variation.
Luciferin-luciferase ATP assay. Hypotonicity-induced ATP release
was quantified by a luciferin-luciferase assay system (ATP Lumines-
cence Kit AF-2L1; DKK-TOA, Tokyo, Japan), as described previ-
ously (25). Briefly, L929 fibrosarcoma cells were cultured to conflu-
ence in 12- or 24-well plates. The 12-well plates were used for studies
on osmolality and time dependence. Pharmacological studies were
carried out using 24-well plates. After the culture medium was fully
replaced with isotonic 50 mM NaCl Ringer solution (1,000 l and 500
l for 12- and 24-well plates, respectively), cells were incubated at
37°C for 60 min. To measure the background ATP release, an aliquot
(100 l) of the extracellular isotonic solution was collected and used
as a reference sample. An osmotic challenge (124–290 mosmol/
kgH2O) was then applied by gently removing most of the remaining
extracellular solution (875 l and 300 l for 12- and 24-well plates,
respectively), adding the hypotonic 50 mM NaCl Ringer solution
(1,000 and 400 l for 12- and 24-well plates, respectively) and
keeping the plates on a plate heater at 37°C. At specified time points,
the plate was carefully rocked to ensure homogeneity of the extracel-
lular solution, and samples (50 l and 20 l for 12- and 24-well
plates, respectively) were collected from each well for the lumino-
metric ATP assay. To the 20-l samples that were collected, 30 l of
the 50 mM NaCl hypotonic solution was added to adjust the final
volume to 50 l, and 500 l H2O was added to make the final volume
550 l. After addition of 50 l of luciferin-luciferase reagent, mea-
surements of the ATP concentration in the samples, all of equal ionic
strength, were made with an ATP analyzer (model AF-100; DKK-
TOA). For pharmacological studies, AG18 and other drugs were
added to the isotonic and hypotonic solution, respectively, to their
final concentration. The luciferin-luciferase assay mixture was sup-
plemented with 600 M EDTA when the samples contained Gd3,
because Gd3 is known to interfere with the luciferin-luciferase
reaction, as reported previously (5). The assay was calibrated using a
standard 100 nM ATP solution free of, or containing, drugs. The drugs
investigated in the present study had no significant effect on the
luciferin-luciferase reaction system.
ATP release after siRNA-mediated gene knockdown was tested in
96-well plates 3 days after transfection. In some experiments, effects
of probenecid and Gd3 on ATP release were also observed in the
cells cultured in 96-well plates. The cells were washed twice with the
isotonic 50 mM NaCl Ringer solution using the automated Cell-
WASHER APW-2000 (Ikeda Scientific, Tokyo, Japan) and incubated
at room temperature for 30 min. The Ringer solution was then
aspirated, and 100 l of a test solution, composed of the isotonic or
hypotonic 50 mM NaCl Ringer solution mixed with the luciferin-
luciferase reagent in a ratio of 9:1, was slowly added to each well.
Cells were incubated for 30 min at 37°C, and the luminescence
intensity was measured using a luminescence microplate reader (Cen-
troPRO LB962; Berthold Technologies, Bad Wildbad, Germany). The
extracellular solution was then replaced with 50 l of Hoechst33342
(Hoechst, Frankfurt, Germany) dissolved in normal Ringer solution,
and Hoechst33342-stained nuclei were counted with the InCell Ana-
lyzer 1000 system (GE Healthcare, Little Chalfont, UK). The total
luminescence intensity (in arbitrary units) for each well was normal-
ized by the cell number to meet the variability in cell number per well
after siRNA treatment.
Cell volume measurement. The mean cell volume was measured at
room temperature using an electronic Coulter-type cell size analyzer
(CDA-500; Sysmex, Kobe, Japan). Trypsinized L929 cells were
suspended in either the isotonic or the hypotonic (124 mosmol/
kgH2O) 50 mM NaCl Ringer solution, and the mean cell volume was
measured until 50 min.
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Ethidium uptake measurement. The L929 cells were cultured to
confluence in 96-well plates for 1 day at 37°C. Culture medium was
fully replaced with 50 l isotonic 50 mM NaCl Ringer solution in the
absence or presence of probenecid (1 mM) or Gd3 (50 M) and
incubated at 37°C for 30 min. The isotonic solution was then replaced
with 50 l of high-K hypotonic solution (50 mM KCl-based Ringer
solution, 124 mosmol/kgH2O with or without probenecid or Gd3)
supplemented with 5 M ethidium bromide. The fluorescence was
measured after 15 min at 37°C using Fluorescence Microplate Reader
(Molecular Devices, Sunnyvale, CA) with the excitation/emission
filter of 544/590 nm. After subtracting the background fluorescence
which was measured in 96-well plates without cells, the fluorescence
measured with cells was normalized to the control value measured at
time zero just before application of the high-K hyptotonic solution.
Microarray analysis. DNA microarray analyses were carried out
with Affymetrix GeneChip Mouse Gene 1.0 ST Arrays according to
the standard Affymetrix protocol. Total RNAs were extracted from
L929 and C127 cells using SEPAZOL (Nacalai Tesque, Kyoto,
Japan), purified with the RNeasy Minikit (Qiagen, Hilden, Germany)
and processed to cDNA (target) using the Ambion WT Expression Kit
(Life Technologies, Carlsbad, CA) and the GeneChip WT Terminal
Labeling and Controls Kit (Affymetrix, Santa Clara, CA). The raw
CEL files were processed for gene-level analysis with median polish
summarization and quantile normalization using Affymetrix Expres-
sion Console 1.1 software, and normalized intensity values were
obtained. To identify up- or downregulated genes, we calculated
Z-scores [z] and ratios (non-log scaled fold change) from the normal-
ized intensity of each gene for comparisons between L929 cells,
which were the experimental sample, and C127 cells, which were the
control. Since an Affymetrix average difference (AD) level of 100 is
thought to correspond to an extremely low or zero level of expression
(53), we only considered genes for which there was an AD value
100. Microarray analysis support was provided by Cell Innovator
(Fukuoka, Japan).
Small interfering RNA transfection. The murine L929 fibrosarcoma
cells were transfected with small interfering (si)RNAs using a reverse-
transfection method. Briefly, an aliquot (2–5 l) of siRNA solution (to
yield a final concentration of 30 or 50 nM) was spread on the bottom
of a 96-well culture plate, and 25 l of serum-free OPTI-MEM
(GIBCO: Life Technology Japan, Tokyo, Japan) containing 0.75 l of
the transfection reagent (Lipofectamine 2000; Invitrogen, Grand Is-
land, NY) was added. After a 10-min incubation, the cells were
seeded by adding 175 l of the cell suspension to give 30%
confluence on the day of transfection. Three to six hours after
transfection, the cells were washed with RPMI plus 10% FBS
culture medium and grown in the same medium for 2– 4 days
before patch-clamp and the ATP release assay. The siRNAs against
the pannexins and connexin 43 were purchased from Sigma-
Aldrich (Panx1, ID: SASI_Mm01_00066664 and Panx2, ID: SA-
SI_Mm02_00286265) and Qiagen (Gja1, ID: Mm_Gja1_4). Fluores-
cence-labeled nontargeting siRNA (AllStars; Qiagen) was used as a
negative control. The transfection efficiency was monitored under a
fluorescence microscope. Nearly all L929 cells were observed to be
successfully transfected under these experimental conditions.
RT-PCR. Molecular expression of the genes (Panx1, Panx2, and
Gja1) in L929 cells and their knockdown by gene-specific siRNAs
were monitored by RT-PCR. Total RNA was isolated from control or
gene-specific siRNA-transfected cells using Sepasol RNA I reagent
(Nacalai Tesque). Genomic DNA contamination of total RNA was
removed by DNaseI treatment (RT-grade; Nippongene, Tokyo, Ja-
pan). cDNA was synthesized using an oligo(dT) primer (Invitrogen)
and the GoScript Reverse Transcription System (Promega, Madison,
WI). The sequences of the gene-specific primers were as follows:
Panx1: forward, 5=-TCTTCTGGCGCTTCTTCTCTGC-3= and re-
verse, 5=-GGTCCAGGTCCGTCTCTTAGG-3= (product size 139
bp); Panx2: forward, 5=-GGAGCTCAACTTCCTTCTTCAG-3= and
reverse, 5=-AGGTGGATGAGGTTGACTAGG-3= (product size 483
bp); and Gja1 (Cx43): forward, 5=-TGCTCCTGGGGACAGCG-
GTT-3= and reverse, 5=-TCCACGTTGACCCCGTCGGT-3= (product
size 291 bp). Expression of GAPDH was monitored as an internal
control. The sequences of the forward and reverse primers for
GAPDH were 5=-ATGGTCTACATGTTCCAGT-3= and 5=-CCTTC-
CACAATGCCAAAG-3=, respectively (product size 392 bp). RT-PCR
was carried out with a Gene Amp PCR System 9600 thermal cycler
(Perkin-Elmer Life Sciences, Boston, MA) under the following cycling
conditions: 10 min at 95°C (initial denaturation), 30–37 cycles of 1 min
at 95°C, 2 min at 50°C (annealing) and 2 min at 72°C (elongation), and
finally, 10 min at 72°C (final elongation).
Data analysis. Single-channel amplitudes were measured manually
by placing a cursor at the open and closed channel levels. The mean patch
currents were measured at the beginning (first 25–30 ms) of current
responses to voltage steps to minimize the contribution of voltage-
dependent current inactivation and the channel occupancy in subconduc-
tance states. Concentration-response data for Gd3-induced inhibition of
the macropatch currents were fitted to the following equation:
I ⁄ Io 1 ⁄ [1 (X ⁄ Kd)h] (1)
where Io and I are the currents in the absence and presence of Gd3
at the concentration of X, respectively, Kd is the apparent dissociation
constant, and h is the Hill coefficient. The concentration-response
curve for Gd3-induced inhibition of the swelling-induced ATP
release was fitted to the following equation:
A (Ao A1) ⁄ [1 (X ⁄ Kd)h] A1 (2)
where Ao and A are the levels of ATP released in the absence and
presence, respectively, of Gd3 at a concentration of X, A1 is the
noninhibited fraction of released ATP, Kd is the apparent dissociation
constant, and h is the Hill coefficient. The ATP to Cl permeability
ratio (PATP/PCl) was calculated from the Goldman-Hodgkin-Katz
equation as described previously (41). Data were analyzed in OriginPro
7 (OriginLab, Northampton, MA). Plotted data are given as means SE of
n observations. Statistical differences of the data were evaluated by
ANOVA, the Tukey honestly significant difference (HSD) test, and
Student’s t-test where appropriate and were considered significant at
P  0.05 or P  0.01 as indicated.
In RT-PCR studies, the densitometric analysis of the amplified
signal band was carried out using ImageJ software (National Institutes
of Health, Bethesda, MD). Normalization was performed using the
housekeeping gene GAPDH.
RESULTS
Activation of maxi-anion channel upon patch excision or
protein tyrosine dephosphorylation. After membrane patches
were excised from murine L929 fibrosarcoma cells, currents
were found to be activated in the inside-out configuration in
which the patches were exposed to normal Ringer solution
applied in both the bath and pipette. A representative time
course of channel activation is shown in Fig. 1A. The observed
single-channel current amplitude was 10.5 0.27 pA (n	 10)
at25 mV and10.4 0.26 pA (n	 12) at25 mV, values
which are close to the previously reported values in other cell
types (46). After patch excision, the number of open channels
increased with time and reached a steady-state level within 4–5
min, as shown in Fig. 1B. At the steady-state level, the opening
of about 12 channels could be detected (data not shown, n 	
15). In response to voltage steps, the steady-state maxi-anion
channel currents showed voltage- and time-dependent inacti-
vation kinetics, as illustrated in Fig. 1C. Voltage-dependent
patch current inactivation occurred in a step-wise manner in
which single-channel closing events could be observed. Such
steady-state peak activation of the channels was found to
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continue for the time period as long as 30 to 50 min, when the
patch excision was performed in artificial intracellular solution
added to the bath (data not shown; n	 7). Under the whole cell
configuration, when the tyrosine kinase inhibitor AG18 was
perfused intracellularly through the patch pipette, the macro-
scopic maxi-anion channel current was activated, even under
normotonic conditions (Fig. 1D), as previously observed in
other cell types (60). Single maxi-anion channel-like events
could be detected early in these whole cell records, as shown in
the inset of Fig. 1D. These results demonstrate that murine
L929 fibrosarcoma cells endogenously express maxi-anion
channels, which can be activated upon membrane patch exci-
sion and tyrosine dephosphorylation.
Single-channel properties and ATP permeability of the
maxi-anion channel. Figure 2A shows representative single-
channel events occurring in response to step pulses applied
Fig. 1. Activation of maxi-anion channel currents in L929 cells. A: representative time course for maxi-anion channel activation after patch excision. The currents
were recorded in the inside-out mode during repetitive application (every 5 s) of alternating test pulses (25 mV for 0.5 s) from the holding potential (0 mV).
B: mean patch currents recorded at 25 mV as a function of time. Arrow indicates the time at which the patch was excised. C: voltage- and time-dependent
inactivation of the steady-state membrane current in response to voltage pulses (500 ms) from holding at 0 mV to 50 mV in 10-mV increments. For A to C,
the pipette and bath solutions were normal Ringer. D: activation of the maxi-anion channel macroscopic current after intracellular application of the tyrosine
kinase inhibitor AG18 (100 M), under the whole cell configuration. The currents were recorded during application of 25-mV test pulses. Inset: single
maxi-anion channel-like events observed in the whole cell mode early after current activation. No drug was added to the pipette solution in control experiments.
For B and D, each data point represents the mean  SE (vertical bar).
Fig. 2. Single-channel properties and ATP
conductivity of the maxi-anion channel in
inside-out membrane patches excised from
L929 cells. A: representative current re-
sponses elicited by step pulses applied from a
holding potential of 0 mV to the voltage
levels indicated at the left of each trace. The
pipette and bath were filled with normal
Ringer solution. The arrowheads indicate the
closed state. B: single-channel current-to-
voltage (I-V) relationships for maxi-anion
channel events recorded as in A. Each symbol
represents the mean value SE (vertical bar).
The solid line is a linear fit with a slope
conductance of 414.9  4.9 pS. C: represen-
tative steady-state ramp I-V records from a
macro-patch exposed to normal Ringer solu-
tion (Ringer) and 100 mM Na4ATP solution
(100 mM ATP4) in the bath. The pipette was
filled with normal Ringer solution. The cur-
rent recorded with ATP in the bath reversed at
14.9  0.7 mV. A ramp pulse was applied
from 50 to 50 mV at a rate of 25 mV/s.
C927MAXI-ANION CHANNEL IS DISTINCT FROM PANNEXIN 1
AJP-Cell Physiol • doi:10.1152/ajpcell.00459.2011 • www.ajpcell.org
 at N
ational Institutes of Natural Sciences on Novem
ber 1, 2012
http://ajpcell.physiology.org/
D
ow
nloaded from
 
from a holding potential of 0 mV to  50 mV in 10-mV
increments. The channel currents exhibited time- and voltage-
dependent inactivation at both positive and negative potentials
greater than  20 mV. Under symmetrical chloride (Cl)
conditions (with normal Ringer solution in the bath and pi-
pette), the single-channel current-to-voltage (I-V) relationship
was linear in the range of  50 mV and reversed at 0 mV, as
shown in Fig. 2B. The unitary slope conductance was 414.9 
4.9 pS (n 	 5).
Since the maxi-anion channels in a number of cell types
have been shown to exhibit significant ATP conductivity (44–
46), we next tested the ATP conductivity of the maxi-anion
channel in L929 cells. Under symmetrical ionic conditions
with normal Ringer solution in both the pipette and bath, the
steady-state I-V relationship determined with ramp pulses in
macropatches containing multiple active channels appeared
sublinear at voltages 15 mV and more negative than 25
mV due to the voltage-dependent inactivation behavior, and
the current reversed at 0 mV (Fig. 2C; Ringer). When all
anions of the bath solution were replaced with 100 mM
ATP4, the inward currents (presumably carried by ATP4
from the bath solution) became smaller (Fig. 2C; 100 mM
ATP4), and the reversal potential shifted to 14.9  0.7 mV
(n 	 5), giving a PATP/PCl value of 0.11  0.01. This value is
similar to the values observed previously for other cell types
(4, 14, 24, 41). These results indicate that this channel can act
as a gateway for the passage of signaling ATP molecules in
fibrosarcoma cells.
Hypotonicity-induced ATP release from L929 cells. When
L929 cells were incubated in normal Ringer solution, the
concentration of extracellular ATP was 1.08  0.21 nM (n 	
7) after a 30-min incubation (Fig. 3A) and remained at a low
level at least up to 50 min (Fig. 3B, filled squares). However,
when the osmolality of the medium was decreased, the level of
extracellular ATP gradually increased, reaching 106.0  6.9
nM (n 	 7) at 124 mosmol/kgH2O (Fig. 3A). When cell
swelling was induced by exposure to a hypotonic solution of
124 mosmol/kgH2O, the concentration of released ATP in-
creased in a time-dependent manner and reached a maximum
level of approximately 120–125 nM within 30 min; the time
course of ATP release had a sigmoidal shape with half-
maximal ATP release observed at around 16 min (Fig. 3B,
filled circles).
Sensitivity of maxi-anion channel currents and hypotonicity-
induced ATP release to extracellular gadolinium. Gadolinium
(Gd3) has been found to be a relatively specific inhibitor of
swelling-induced ATP release (5, 40). Gd3 can also poten-
tially block the maxi-anion channel when it is applied from the
extracellular, but not cytosolic, side (46). Therefore, we exam-
ined the concentration-dependent effects of Gd3 on both
maxi-anion channel currents recorded in the outside-out patch
configuration and hypotonicity-induced ATP release in L929
Fig. 4. Effects of gadolinium on the maxi-anion channel current, the hypotonicity-induced ATP release, and cell volume regulation in L929 cells. A: normalized
mean patch current recorded from membrane patches in the outside-out configuration (Œ, n 	 3–6) and normalized swelling-induced ATP release during
hypotonic stress (124 mosmol/kgH2O) (, n 	 5), as a function of Gd3 concentration. The data were fitted to the Hill equation, with IC50 	 46  25 M for
the currents and IC50 	 73  11 M for ATP release. The Hill coefficients were 1.1  0.7 and 1.1  0.2 for the patch current and ATP release, respectively.
Each symbol represents the mean  SE (vertical bar). B: effects of apyrase (10 U/ml), Gd3 (500 M), or probenecid (1 mM) on regulatory volume decrease
(RVD) in L929 cells. The relative mean cell volume was measured in either isotonic () or hypotonic () solution (290 or 124 mosmol/kgH2O) and in hypotonic
solution supplemented with apyrase (), Gd3 (Œ), or probenecid (}). Hypotonic stimulation was applied at time zero. Each data point represents the mean 
SE (vertical bar). *P  0.05 vs. hypotonic control. The mean cell volume was normalized to the initial value (observed at 0 min) with isotonic solution.
Fig. 3. Osmolality dependence and time course of
hypotonicity-induced ATP release from L929
cells. A: the concentration of released ATP as a
function of osmolality of the extracellular solu-
tion. B: ATP release as a function of time after
application of a control isotonic () or hypotonic
() solution (290 or 124 mosmol/kgH2O). Each
symbol represents the mean  SE (vertical bar).
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cells. As shown in Fig. 4A (open circles), the mean steady-state
patch current sharply decreased (by70%) with an increase in
the concentration of extracellular Gd3 from 25 to 100 M,
and it was nearly completely inhibited at a concentration of 500
M. An IC50 of 46  25 M and Hill coefficient of 1.1  0.7
M were estimated for channel current inhibition by fitting the
data to the Hill equation (Eq. 1). A similar concentration-
response curve was observed when different concentrations of
Fig. 6. Effects of antagonists of pannexin and the maxi-anion channel on hypotonicity-induced ATP release from L929 cells cultured in 24-well plates. Each
column represents the mean  SE (vertical bar) (n 	 10). All the values were corrected for the basal ATP release occurring under isosmotic conditions. *P 
0.05 vs. control; **P  0.01 vs. control or between two designated values. A: effects of the pannexin antagonists probenecid (1 mM) and mefloquine (0.1 M),
and the maxi-anion channel antagonists Gd3 (50 M) and arachidonate (40 M), on the ATP release occurring in response to hypotonic stimulation (124
mosmol/kgH2O). ND, no significant difference. B: effect of the pannexin mimetic peptide 10Panx1 (8 g/ml) on the hypotonicity-induced ATP release from L929
cells. C: effects of brefeldin A (5 M) and bafilomycin A1 (5 M) on the ATP release from L929 cells.
Fig. 5. Pharmacological profile of the maxi-
anion channel currents in patches excised
from L929 cells. A: representative single-
channel current traces recorded in the inside-
out mode [for arachidonic acid, SITS, and
5-nitro-2-(3-phenylpropylamino)-benzoate
(NPPB), which were added from the intracel-
lular side] or outside-out mode (for Gd3,
which was added from the extracellular side)
in the absence (control) or presence of Gd3
(500 M), arachidonate (20 M), SITS (100
M), or NPPB (100 M). The test pulse
protocol is shown at the top. Recording con-
ditions were as in Fig. 2. B: inhibitory effects
of these drugs on the mean currents recorded
at 25 mV in excised macropatches contain-
ing multiple maxi-anion channels. C: effects
of the pannexin antagonists probenecid (1 mM)
and mefloquine (0.1 M), added from the
extracellular side, on the maxi-anion channel
currents recorded in the inside-out mode.
D: effect of the pannexin mimetic peptide
10Panx1 (8 g/ml) on the maxi-anion channel
currents measured in the inside-out mode.
The mimetic peptide was added from both the
intracellular and the extracellular sides 8 min
before and during recordings. Each column in
B–D represents the mean  SE (vertical bar).
*P  0.05 vs. control.
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Gd3 were tested on the hypotonicity-induced ATP release
from L929 cells (Fig. 4A, filled circles). An IC50 of 73  11
M and Hill coefficient of 1.1  0.2 M were obtained for
ATP release inhibition by fitting the data to the Hill equation
(Eq. 2). These data support the idea that the maxi-anion
channel constitutes a major pathway for the swelling-induced
release of ATP from fibrosarcoma cells. This inference was
further supported by the observation that significant release of
ATP could be evoked by treating the L929 cells with a tyrosine
kinase inhibitor, AG18, even under isotonic conditions. In
these experiments, the extracellular ATP concentration in-
creased from 0.98 0.13 nM (n	 25) to 2.12 0.26 nM (n	
25; P  0.05 vs. control) after 10-min incubation with AG18
(100 M).
Facilitation of cell volume regulation by swelling-induced
ATP release. L929 fibrosacroma cells rapidly (within 1 min)
responded to hypoosmotic stimulation (124 mosmol/kgH2O)
with osmotic swelling, but restored their volume to60% after
50 min (Fig. 4B, circles), a process termed regulatory volume
decrease (RVD). The RVD was almost completely inhibited by
the removal of extracellular ATP with 10 U/ml apyrase or by
addition of 500 M Gd3 (Fig. 4B, triangles). In contrast,
probenecid (1 mM) failed to affect the RVD process (Fig. 4B,
diamonds). These results suggest that swelling-induced ATP
release plays a facilitatory role in the cell volume regulation in
fibrosacroma cells, and that the maxi-anion channel activity is
critical for this process.
Insensitivity of maxi-anion channel currents to pannexin
antagonists. Effects of a number of anion channel blockers on
maxi-anion channel currents recorded at  25 mV are shown
in Fig. 5, A and B. Maxi-anion channel activity was drastically
inhibited by Gd3 and arachidonate, in agreement with obser-
vations in mammary C127 cells (13, 41), cardiac myocytes
(14), and cultured astrocytes (24). The maxi-anion channel
current was also partially sensitive to the conventional anion
channel inhibitors SITS and NPPB (Fig. 5B), consistent with
previous observations in other cell types (12, 14, 23, 41).
To test the possibility that the hemichannel function of
pannexins underlies maxi-anion channel activity, we first
tested the effects of the relatively specific pannexin hemichan-
nel blockers probenecid (51) and mefloquine (20). As shown in
Fig. 5C, neither probenecid (1 mM) nor mefloquine (0.1 M)
was effective in blocking the maxi-anion channel currents
activated after patch excision from L929 cells. We then tested
the effect of a pannexin mimetic peptide, 10Panx1 (8 g/ml),
which specifically blocks pannexin 1 hemichannel activity
(36), on the maxi-anion channel currents. However, the peptide
did not have any suppressive effect on the maxi-anion currents,
as shown in Fig. 5D. These pharmacological data strongly
suggest that the maxi-anion channel is distinct from the pan-
nexin 1 hemichannel.
Sensitivity of swelling-induced ATP release to maxi-anion
channel blockers and pannexin antagonists. Functional expres-
sion of pannexin hemichannels in L929 cells was examined by
the uptake of cationic dye, ethidium, under high-K hypo-
tonic conditions, because the activity of pannexin 1 hemichan-
nels monitored by cationic dye uptake is known to be stimu-
lated by high-K-induced depolarization and/or hypotonicity
(37, 50, 62). The ethidium fluorescence increased to 360.9 
22.5% (n 	 20) 15 min after stimulation with high-K hypo-
tonic solution. The ethidium uptake was significantly sup-
pressed to 220.3  23.7% (n 	 19) in the presence of the
pannexin antagonist probenecid (1 mM), whereas the dye
uptake (to 364.6  33.1%, n 	 18) was not significantly
affected by the maxi-anion channel blocker Gd3 (50 M).
Thus, there arises a possibility that pannexins contribute to the
swelling-induced release of ATP from the fibrosarcoma cells.
We then tested the effect of probenecid, which can differentiate
pannexins from connexins (29, 51), on hypotonicity-induced
ATP release. As shown in Fig. 6A, 1 mM probenecid inhibited,
by 18%, the ATP release from L929 cells. A similar extent
of inhibition was observed for another relatively selective
pannexin blocker, mefloquine (0.1 M). Moreover, hypotonic-
ity-induced ATP release was also inhibited by the pannexin
mimetic peptide 10Panx1 (8 g/ml) (Fig. 6B). These findings
suggest that pannexin 1 may represent one of the pathways for
the ATP release that occurs upon a hypotonic challenge.
The contribution of the maxi-anion channel was tested by
applying gadolinium and arachidonic acid. Arachidonate (40
Fig. 7. Effects of small interfering (si)RNA-mediated knockdown of Panx1
expression on the maxi-anion channel currents and swelling-induced ATP
release in L929 cells cultured in 96-well plates. Experiments were conducted
3 days after transfection with 30 nM siRNA. A: expression of Panx1 mRNA
after treatment with nontargeting siRNA (control) or Panx1-specific siRNA,
analyzed by RT-PCR. GAPDH was used as an internal control. The mean
inhibition of the Panx1 signal was 78.3% in triplicate experiments (estimated
by densitometric analysis with normalization to the GAPDH signal). B: the
mean maxi-anion channel currents observed at 25 mV in excised patches
after transfection with the negative control or Panx1-specific siRNA. C: ATP
release induced by hypotonicity (124 mosmol/kgH2O) after siRNA treatment.
The luminescence values [in arbitrary units (AU)] were normalized by the cell
number after correcting for the basal ATP release occurring under isos-
motic conditions. *P  0.05 vs. control. D: ATP release induced by
hypotonicity in the absence or presence of probenecid (1 mM). *P  0.05
vs. control.
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M) and Gd3 (50 M) inhibited hypotonicity-induced ATP
release from L929 cells cultured in 24-well plates by approx-
imately 39% and 43%, respectively (Fig. 6A). Gd3-induced
inhibition (by 38.4  0.006%, n 	 20) of swelling-induced
ATP release was similarly observed in the cells cultured in
96-well plates. When probenecid was added together with
arachidonate or Gd3, ATP release was further inhibited (Fig.
6A). Such additive effects imply that the maxi-anion channel
and the pannexin hemichannel most likely constitute separate,
individual pathways for the release of ATP in murine fibrosar-
coma cells.
Recently, exocytosis has also been found to be one of the
pathways contributing to some extent to the ATP release in
bovine ciliary epithelial cells (26) as well as other cell types (1,
38, 56, 57). We tested this possibility by applying the exocy-
tosis blockers brefeldin A (5 M) and bafilomycin A1 (5 M).
However, neither of these drugs inhibited the hypotonicity-
induced ATP release from L929 cells (Fig. 6C), suggesting that
in fibrosarcoma L929 cells, exocytosis is not involved in ATP
release.
Molecular expression pattern of pannexins and connexins in
L929 cells analyzed by microarray. Before testing siRNA-
mediated knockdown of specific genes, we verified the expres-
sion of pannexins and connexins by DNA microarray analysis.
This analysis showed that pannexins 1 and 2 are moderately
expressed while pannexin 3 is below the threshold expression
level. So far, among a large number of connexin (Cx) family
members, ATP release has been reported to be mediated by
Cx43 (17, 35), Cx32 (9), and Cx26 (19). For L929 cells, a
strong Cx43 signal was detected while signals for Cx32 and
Cx26 were far below the threshold. These results indicate that
L929 cells predominantly express Cx43. Based on the results
from this high-throughput gene expression analysis, we then
tested the effects of siRNA-mediated knockdown of pannexin
1, pannexin 2, and Cx43.
Insensitivity of the maxi-anion channel current and sensitiv-
ity of hypotonicity-induced ATP release to pannexin 1 and
connexin 43 gene silencing. Transfection of L929 cells with
Panx1-specific siRNA suppressed the expression of pannexin 1
mRNA by 78% compared with the control nontargeting
siRNA (mock), as shown in Fig. 7A. However, the amplitude
of the mean patch current observed in Panx1-siRNA-trans-
fected L929 cells was not significantly different from that
observed in the mock-transfected control cells (Fig. 7B).
This clearly indicates that the Panx1 gene product is differ-
ent from the maxi-anion channel. However, the hypotonic-
ity-induced ATP release from L929 cells cultured in 96-well
plates was significantly suppressed by Panx1-siRNA (Fig.
7C) and by probenecid (Fig. 7D). These results suggest that
pannexin 1 serves as one of the pathways for swelling-
induced ATP release from L929 cells, but that pannexin 1
and the maxi-anion channel are independent of each other.
Although treatment with Panx2-specific siRNA largely
eliminated (by 94%) the expression of Panx2 mRNA (Fig.
8A), neither maxi-anion channel activity (Fig. 8B) nor swell-
ing-induced ATP release (Fig. 8C) was affected by this ma-
neuver. These findings indicate that pannexin 2 is not involved
in ATP release and also that it is distinct from the maxi-anion
channel in L929 cells.
The general connexin hemichannel blocker 1-octanol had no
significant effect on maxi-anion channel activity or swelling-
induced ATP release (Fig. 9, A and B). The connexin 43
mimetic peptide Gap27 (15) had no effect on maxi-anion
channel activity (Fig. 9B) but slightly decreased the swelling-
induced ATP release (Fig. 9A). Connexin 43 (Gja1)-specific
siRNA treatment largely suppressed (by73%) the expression
of connexin 43 mRNA (Fig. 9C) but had no effect on maxi-
anion channel activity (Fig. 9D). The lack of any effect of
1-octanol, Gap27, or Cx43-specific siRNA on the maxi-anion
channel currents indicates that connexin 43 and the maxi-anion
channel are unrelated entities.
DISCUSSION
L929 cells functionally express the ATP-conductive maxi-
anion channel. Under resting conditions, the maxi-anion chan-
nel normally remains in a dormant state; upon stimulation by
several kinds of stimuli, it is activated in a large variety of cell
Fig. 8. Effects of siRNA-mediated knockdown of Panx2 expression on the maxi-anion channel currents and swelling-induced ATP release in L929 cells.
Experiments were conducted 3 days after transfection with 50 nM siRNA. A: expression of Panx2 mRNA after treatment with nontargeting siRNA (control) or
Panx2-specific siRNA, analyzed by RT-PCR. GAPDH was used as an internal control. The mean inhibition of the Panx2 signal was 93.8% in duplicate
experiments (estimated by densitometric analysis with normalization to the GAPDH signal). B: the mean maxi-anion channel currents observed at 25 mV in
excised patches after transfection with the negative control or Panx2-specific siRNA. C: ATP release induced by hypotonicity (124 mosmol/kgH2O) after siRNA
transfection. The luminescence values (in AU) were normalized by the cell number after correcting for the basal ATP release occurring under isosmotic
conditions.
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types (46). In our previous studies, we reported the activation
of the maxi-anion channel in mammary C127i cells (41),
astrocytes (25), and cardiomyocytes (12, 14) by osmotic cell
swelling, in kidney macula densa cells by salt stress (4), and in
cardiomyocytes and astrocytes by ischemia/hypoxia (14, 23,
24). Among all the activation stimuli used in these studies,
patch excision was found to be the strongest. The mechanism
of channel activation has not yet been completely clarified.
However, a recent study by Toychiev et al. (60) showed that
phosphorylation of tyrosine residues of the maxi-anion channel
or a regulatory subunit keeps the channel in the closed state,
and that upon patch excision, the channel is activated by
protein tyrosine phosphatase-mediated dephosphorylation. In
the present study, we observed a robust activation of the
maxi-anion channel in L929 fibrosarcoma cells by both patch
excision (in the inside-out mode) and intracellular application
of the tyrosine kinase inhibitor AG18 (in the whole cell mode)
(Fig. 1). The activated maxi-anion channel displayed a linear
current-voltage (I-V) relationship, a large single-channel con-
ductance of 415 pS, permeability to ATP4 (Fig. 2), and
sensitivity to Gd3 and arachidonic acid (Fig. 5). These prop-
erties of the maxi-anion channels in L929 cells are identical to
those observed in other cell types (46). Thus, it is concluded
that the maxi-anion channel is endogenous to, and functional
in, murine L929 fibrosarcoma cells.
Maxi-anion channel and pannexin 1 are separate, distinct
entities. The maxi-anion channel and the recently character-
ized pannexin 1 hemichannel display the following overlap-
ping properties: 1) both the maxi-anion channel (46) and
pannexin 1 (11) are ubiquitously expressed; 2) both the
maxi-anion channel (41) and pannexin 1 (39) are activated
by osmotic cell swelling; 3) the pore radius of the maxi-
anion channel is approximately 1.3 nm (43) and that of
pannexin is approximately 1.7–2.1 nm (2); 4) the maxi-
anion channel and pannexin 1 hemichannel have large
single-channel conductances of approximately 300 – 450 pS
(46) and 300 –550 pS (3, 22, 58), respectively, with several
subconductance states; 5) no rectification was reported for
the maxi-anion channel (46) and little or no outward recti-
fication was reported for the pannexin 1 hemichannel (3, 22,
30, 58); 6) both the maxi-anion channel (4, 14, 24, 41) and
pannexin 1 hemichannel (3) are permeable to ATP; and 7)
both the maxi-anion channel (12, 14, 23, 41) and pannexin
1 (29) are partially sensitive to SITS, NPPB and DIDS.
Based on these similarities, we hypothesized that the pan-
nexin 1 hemichannel could be the molecular correlate of the
maxi-anion channel. However, we found that maxi-anion
channel activity was not sensitive to known blockers of
pannexin 1 such as probenecid, mefloquine, and 10Panx1
(Fig. 5). Microarray and RT-PCR data revealed low but
detectable expression of pannexin 1 in L929 cells. However,
we did not observe any difference in the maxi-anion channel
currents recorded from mock- and Panx1-specific siRNA-
transfected L929 cells despite a large decrease in mRNA
expression due to Panx1 siRNA transfection (Fig. 7). Based
on these electrophysiological and pharmacological data we
conclude that the maxi-anion channel and pannexin 1 hemi-
channel are separate, distinct entities. Our conclusion is
supported by reported differences between the properties of
these two channels which include the following: 1) the
maxi-anion channel is inhibited by Gd3 (46), whereas
pannexin 1 is insensitive to it (29, 36); and 2) the maxi-
anion channel is highly anion selective (45, 46), while the
pannexin 1 hemichannel supposedly has a nonselective
cation pore (3, 22, 58).
Hypotonicity-induced ATP release occurs via maxi-anion
channels and pannexin hemichannels but not by exocytosis.
The fibrosarcoma maxi-anion channel was found to be
permeable to ATP, a prerequisite for its role as an ATP-
conductive pathway. The sensitivity of the hypotonicity-
induced ATP release from L929 cells to Gd3 (Figs. 4 and
6) and arachidonic acid (Fig. 6) strongly suggests that a
major portion of the released ATP passes through the
fibrosarcomal plasmalemma via the maxi-anion channel.
This result is consistent with our previous observations on
the role of the maxi-anion channel in the release of ATP
from mammary C127 cells (41), macula densa cells (4),
cardiomyocytes (12, 14), and astrocytes (25). On the other
hand, the functional expression of the pannexin hemichan-
nels in L929 cells was indicated by the ethidium uptake
Fig. 9. Effects of the connexin inhibitor 1-octanol, the connexin 43 (Cx43)
mimetic peptide Gap27 and Gja1-specific siRNA-mediated Cx43 knockdown
on swelling-induced ATP release and/or the maxi-anion channel currents in
L929 cells. A: ATP release induced by hypotonic stress (124 mosmol/kgH2O)
without drug treatment (control) and after a 20-min preincubation with 1-
octanol (1 mM) or Gap27 (8 g/ml). *P  0.05 vs. control. B: excision-
induced maxi-anion channel currents in the absence (control) or presence of
1-octanol (1 mM) or Gap27 (8 g/ml). For the Gap27 experiment, the cells
were also preincubated with this peptide for 20 min. C: expression of Gja1
(Cx43) mRNA in L929 cells treated with nontargeting (control) siRNA or
Gja1-specific siRNA (Cx43-siRNA), 3 days after transfection (with 50 nM),
analyzed by RT-PCR. GAPDH was used as an internal control. The mean
inhibition of the connexin 43 signal was 72.8% in duplicate experiments
(estimated by densitometric analysis with normalization to the GAPDH sig-
nal). D: effects of the negative control and Gja1-specific siRNA on the
maxi-anion channel currents recorded at 25 mV. Each column in A, B, and
D represents the mean  SE (vertical bar).
C932 MAXI-ANION CHANNEL IS DISTINCT FROM PANNEXIN 1
AJP-Cell Physiol • doi:10.1152/ajpcell.00459.2011 • www.ajpcell.org
 at N
ational Institutes of Natural Sciences on Novem
ber 1, 2012
http://ajpcell.physiology.org/
D
ow
nloaded from
 
assay. The swelling-induced ATP release was partially sup-
pressed by the pannexin hemichannel inhibitors probenecid
and mefloquine as well as by the pannexin 1-blocking
peptide 10Panx1 (Fig. 6). We further confirmed the involve-
ment of the pannexin 1 hemichannel in the swelling-induced
ATP release by using siRNA-mediated Panx1 knockdown
(Fig. 7). These data indicate that both the maxi-anion
channel and the pannexin 1 hemichannel are involved in the
ATP release from fibrosarcoma L929 cells.
Our present results supporting the role of pannexin 1 in the
ATP release from fibrosarcoma cells are consistent with pre-
vious observations of a similar role for it in erythrocytes (28,
32, 37, 52), airway epithelial cells (39, 49), astrocytes (16, 21),
ciliary epithelial cells (26), the pituitary gland (27), apoptotic
lymphoidal Jurkat cells (7), microglia, and neurons (35). As
shown in Fig. 6, A and B, the inhibitory effect of a highly
pannexin-specific blocker, 10Panx1 (by 8.4  1.7%), was less
marked than the effect of probenecid (by 18.1  4.1%; P 	
0.04) and looked less marked than that of mefloquine (by 16.4
 3.8%; P 	 0.07). Thus, it is possible that these nonspecific
blockers inhibited some minor ATP release pathway other than
pannexin 1. In contrast to pannexin 1, however, pannexin 2
plays no role in the ATP release, as we did not find any
inhibitory effect of Panx2-specific siRNA treatment on the
hypotonicity-induced ATP release (Fig. 8). Two different
blockers of exocytosis, brefeldin A and bafilomycin A1, failed
to inhibit the hypotonicity-induced ATP release from L929
cells, indicating that exocytosis does not play a role in the ATP
release in these cells.
Connexin 43 and the maxi-anion channel are distinct entities
in L929 cells. The connexin 43 hemichannel has long been
under consideration as a possible pathway for the stimulated
release of ATP in astrocytes (16, 35), microglia (35), cardio-
myocytes (17, 48, 58, 59), and bovine ciliary epithelial cells
(26). Therefore, a possible relationship between connexin 43
and the maxi-anion channel could be hypothesized, and in the
present study, we attempted to test this possibility in L929
cells. We found that both the nonspecific connexin inhibitor
1-octanol and the connexin 43-specific peptide blocker Gap27
had no effect on maxi-anion channel activity (Fig. 9B). More-
over, the Gja1 siRNA-mediated knockdown of connexin 43
had no effect on maxi-anion channel activity (Fig. 9D) even
though connexin 43 mRNA expression was largely eliminated
(Fig. 9C). Based on these data, we conclude that the maxi-
anion channel and the connexin 43 hemichannel are distinct
from each other.
A possible physiological function of swelling-induced ATP
release. Released ATP may play a role in autocrine and/or
paracrine cell-to-cell signaling via stimulation of purinergic
receptors. ATP released from osmotically swollen cells has
been shown to facilitate the process of RVD (6, 8, 10, 18, 34,
61). In L929 cells, it would be also the case, because their RVD
ability was abolished by extracellular application of an ATP-
hydrolyzing enzyme, apyrase (Fig. 4B, reversed triangles). The
RVD response to hypotonic stimulation was also almost com-
pletely eliminated by Gd3 (Fig. 4B, triangles). Thus, it ap-
pears that ATP released locally via Gd3-sensitive maxi-anion
channels plays, in an autocrine manner, a facilitatory role in the
cell volume regulation after osmotic swelling in L929 fibro-
sarcoma cells. In contrast, the RVD process was not signifi-
cantly affected by probenecid (Fig. 4B, diamonds). Thus, it
may be inferred that probenecid-sensitive pannexin 1 hemi-
channels, which represent a minor pathway for ATP release
(Fig. 6A), exist remote from purinergic receptors on the plasma
membrane.
Conclusion. The maxi-anion channel and the pannexin 1 and
connexin 43 hemichannels have been identified as possible
ATP release pathways in different cell types. These channels
are known to share some common biophysical and pharmaco-
logical properties. The present study, however, demonstrated
that the maxi-anion channel is a distinct molecular entity from
the pannexin 1 and connexin 43 hemichannels and that the
maxi-anion channel and hemichannels serve as separate path-
ways for swelling-induced ATP release in murine L929 fibro-
sarcoma cells.
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